| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
9 companies
Armistice Capital, LLC is a 10% Owner at HIND with holdings across 9 companies. Recent SEC Form 4 filings include 23 buys and 35 sells.
Estimated insider holdings value: $55.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2019 | VXRT Vaxart, Inc. | 10% Owner | Buy | 7,333,333 | $0.29 | $2,143,078.47 | +5.7% | |
| Sep 23, 2019 | TRAW Traws Pharma, Inc. | 10% Owner | Sell | 10,249 | $1.27 | $13,016.23 | -0.6% | |
| Sep 6, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 2,200,000 | $3.05 | $6,706,000.00 | +3.7% | |
| Aug 30, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 41,764 | $3.22 | $134,554.26 | +0.1% | |
| Aug 19, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 12,184 | $3.46 | $42,189.23 | - | |
| Aug 14, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 100,000 | $3.33 | $332,581.94 | +10.4% | |
| Jun 11, 2019 | ACHV Achieve Life Sciences, Inc. | 10% Owner | Sell | 264,963 | $3.16 | $837,467.28 | -1.0% | |
| Jun 11, 2019 | ACHV Achieve Life Sciences, Inc. | 10% Owner | Sell | 49,382 | $2.86 | $141,442.70 | -1.2% | |
| Jun 11, 2019 | ACHV Achieve Life Sciences, Inc. | 10% Owner | Buy | 12,813 | $3.80 | $48,689.40 | +1.3% | |
| Jun 7, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 10,000 | $4.88 | $48,750.00 | +1.7% |